Published

Ceryx Medical Initiates First-In-Human Study of the Cysoni™ RSA Pacemaker - Digital Health Technology News

Summary by Digital Health Technology News
Ceryx’s Cysoni pacing technology is designed to provide superior therapeutic outcomes for Heart Failure patients by improving cardiac output using Respiratory Sinus Arrythmia (RSA) inputs to inform the pacing algorithm. RSA is the natural synchronisation of the heart and lungs that maximises cardiac efficiency and output, RSA is frequently absent in Heart Failure patients. Ceryx’s Cysoni pacing technology has been proven to increase cardiac outp…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)